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Key Points
1. Rates of nonadherence among pediatric transplant
recipients are as high as 50% to 65%, and this places
adolescent transplant recipients at increased risk.
2. Adherence to immunosuppressant medications is
a critical factor in the transition process as poor med-
ication adherence is associated with an increased risk
of poor long-term health outcomes.
3. Before transferring to adult-centered care, the
pediatric transplant recipient should demonstrate
adequate regimen knowledge and self-management
skills.
4. Future research is needed to identify factors and
interventions that affect long-term health outcomes in
pediatric transplant recipients, including factors re-
lated to nonadherence and the successful transfer
from pediatric care to adult-centered care. Liver
Transpl 15:S63-S69, 2009. © 2009 AASLD.
In 2007, 605 children under the age of 18 years re-
ceived liver transplants, accounting for approximately
9% of all liver transplants in the United States.1 Among
pediatric liver transplant recipients, patient survival
rates are 90% at 1 year, 82% at 5 years, and 80% at 10
years post-transplantation.1,2 There have been signifi-
cant improvements in the survival of pediatric liver
transplant recipients, and they are reaching adulthood
at increased rates. Although the number of new pedi-
atric liver transplant recipients remains relatively sta-
ble each year, the population of long-term survivors
following liver transplantation has grown. With in-
creased short-term survival rates, health care providers
have shifted their focus to long-term outcomes. Long-
term patient survival is limited by chronic rejection and
graft loss, which is more common in adolescents.3
Given the risk of medical complications following the
transfer of care, there is a critical need to develop strat-
egies to promote adherence and a successful transition
from pediatric care to adult-centered health care.4-6
MEDICATION NONADHERENCE IN PEDIATRIC
TRANSPLANTATION
The World Health Organization defines adherence as
“the extent to which a person’s behavior—taking
medication, following a diet, and/or executing life-
style changes, corresponds with agreed recommenda-
tions from a health care provider.”7 Regimen adher-
ence is broader than taking immunosuppressive
medications as it also encompasses other health be-
haviors, such as diet and exercise. However, research
has primarily focused on the impact of nonadherence
to immunosuppressant medications.8 Nonadherence
to posttransplant medications is associated with sig-
nificant consequences, including increased medical
complications, graft rejection, posttransplant mortal-
ity, psychological distress, family dysfunction, and
poor health-related quality of life.9-12 Moreover, non-
adherence in pediatric transplant recipients has the
potential to negatively affect long-term health out-
comes and quality of life, particularly during the tran-
sition from pediatric health care to adult-centered
health care.4,5
Adolescent transplant recipients are at an in-
creased risk for medication nonadherence. A recent
review of the prevalence of nonadherence among ad-
olescent transplant recipients revealed that nonad-
herence ranged from 17% to 53% among liver trans-
plant recipients and from 5% to 71% among renal
transplant recipients.13 The rate of medication non-
adherence among adolescent transplant recipients is
approximately 4 times higher than that among adult
transplant recipients.14 These nonadherence rates
are a concern as this is the population of patients that
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is closest to transferring their medical care to a new
provider as they move from pediatric transplant ser-
vices to adult-centered transplant services.
ASSESSMENT OF MEDICATION ADHERENCE
IN TRANSPLANTATION
Although nonadherence to immunosuppressive medi-
cations has been estimated to be as high as 50% to
65%,13,15 the rates of nonadherence vary with the
method of assessment and the definition of nonadher-
ence. Within the adherence literature, it is common to
define nonadherence as less than 80% to 85% compli-
ance with medication taking.16 However, it is generally
agreed that to increase the likelihood of favorable out-
comes in transplantation, nearly perfect (ie, 100%) ad-
herence should be the goal, as minor deviations from a
dosing schedule have been shown to be associated with
negative outcomes.17,18 On the basis of a recent non-
adherence consensus conference, nonadherence was
defined as a “deviation from the prescribed medication
regimen sufficient to influence adversely the regimen’s
intended effect.” Yet, to date, studies of medication ad-
herence in pediatric transplantation have been limited
by a lack of an accepted gold-standard method for as-
sessing adherence.
Medication adherence can be measured with various
strategies. Patient/caregiver self-reports may be the
least costly and feasible way to monitor adherence;
however, self-reported adherence is often less accu-
rate.19 Electronic medication monitoring technology,
such as the Medication Event Monitoring System
(MEMS; Aprex Corp.), is considered a recommended
measure in adherence research.20 MEMS technology
provides continuous data and allows for the detection of
temporal patterns of adherence.19 Yet, barriers associ-
ated with MEMS technology include its cost and the
possibility that these devices may interfere with estab-
lished adherence routines such as the use of pillbox
organizers.21 Recent studies have attempted to mea-
sure adherence objectively by using the degree of fluc-
tuation (ie, standard deviation) of medication blood
levels of tacrolimus in pediatric liver transplant recipi-
ents.11,14,22,23 Higher standard deviations were predic-
tive of clinical outcome, such as biopsy-proven rejec-
tion14,22,23 and hospitalization rates.11 Variability in
the blood levels of the immunosuppressant cyclospor-
ine have also been associated with an increased risk of
rejection in pediatric heart transplant recipients.24
Blood levels of cyclosporine (outside 150-400 ng/mL) or
tacrolimus (outside 5-17 ng/mL) outside the therapeu-
tic range have also been shown to be indicators of poor
adherence.25
Each approach to measuring medication adherence
has strengths and weaknesses, and this suggests a
need for a multimethod assessment strategy.26 A recent
study showed that a multimethod approach that in-
cluded self-reports, drug assays, and clinician reports
yielded the highest sensitivity (72%) and specificity
(42%) in comparison with electronic monitoring
alone.27 Future studies should focus on developing a
standardized method for assessing medication adher-
ence in transplant recipients.
MEDICATION NONADHERENCE AND THE
TRANSITION TO ADULT CARE
The transition from pediatric health care to adult-cen-
tered health care is part of the developmental process
for those with chronic childhood diseases and disabili-
ties. In discussions of transition, there is often confu-
sion between transition and transfer. The term transi-
tion refers to a complex set of beliefs, skills, and
processes that facilitate the movement from pediatric
care to adult-centered care, whereas the term transfer
refers to the change in the location at which care is
provided.28 Transition refers to the a multifaceted, ac-
tive process that addresses the medical, psychosocial,
and educational/vocational needs of adolescents as
they prepare to move from child-centered health care to
adult-centered health care.29 The transfer of care is
only one outcome of the transition process and does not
mark the end of the transition process, which should
continue into adult-centered care.30
Medication adherence is considered a critical factor
in the transition process because of an association be-
tween nonadherence and an increased risk of poor
health outcomes, including increased graft loss and
rejection, following the transfer from pediatric care to
adult-centered care.4,5 A review of 20 patients who
transferred from a pediatric renal transplant clinic to
an adult renal transplant clinic revealed a high rate of
unanticipated graft loss (35%) within the first 3 years of
transfer.5 For those with graft loss, the authors con-
cluded that medication nonadherence was likely a con-
tributing factor to the graft loss. In addition, a retro-
spective chart review of 14 pediatric transplant
recipients who had transitioned to the adult service
revealed that adherence to immunosuppressant medi-
cations significantly declined after the transfer of care,
and medication adherence was significantly poorer in
the newly transitioned cohort in comparison with pedi-
atric and adult cohorts.4 Thus, the promotion of medi-
cation adherence behavior is a vital component of the
transition process.
In a recent study, we conducted a retrospective anal-
ysis of pediatric liver transplant recipients who com-
pleted a clinically derived transition readiness screen-
ing measure used to assess regimen knowledge and
self-management skills.31 Adherence was assessed
with a multimethod approach incorporating standard
deviations of consecutive blood levels of immunosup-
pressant medication, the proportion of immunosup-
pressant blood levels in the target therapeutic range,
and the rate of clinic attendance. A composite adher-
ence score was also constructed as an overall measure
of adherence. Seventy-one pediatric liver transplant re-
cipients were identified. The mean age of the partici-
pants was 15.6  2.7 years, and the mean time since
transplant was 9.4  5.4 years. The results indicated
that though the majority of adolescents correctly
named their primary immunosuppressant medication,
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less than half could correctly state the prescribed dose/
timing or the basic function of their immunosuppres-
sant. With respect to self-management skills, approxi-
mately half of the participants reported taking
medications without parental prompting, though only
27% took their medications without parental supervi-
sion. The frequency of parental prompting for medica-
tion was significantly related to age, with older partici-
pants receiving less prompting. Rates of nonadherence
ranged from 26% to 32%. Poorer adherence was signif-
icantly related to older age and increased independence
in medication taking. These results suggest that in-
creased age is associated with decreased parental su-
pervision and increased nonadherence.31
Research suggests an association between medica-
tion adherence, self-management skills, and health
outcomes following the transfer from pediatric care to
adult-centered care. Although medical regimen adher-
ence may not be sufficient to lead to a successful tran-
sition process and transfer of care, it is necessary for
optimal long-term health outcomes.32 Medication ad-
herence behavior can be modified with intervention and
should be targeted in transition preparation.
DEVELOPMENTAL ISSUES IN SELF-
MANAGEMENT AND TRANSITION
The adolescent developmental period is characterized
by changes in cognition, emotional attachments, phys-
ical development, independence, education/vocation,
and self-identity.33 This stage of development is a crit-
ical period for the establishment of both positive and
risky lifelong health-related behaviors. With respect to
chronic illness, disease management, including medi-
cation adherence, is often at odds with typical adoles-
cent development.34,35 The developmental characteris-
tics associated with adolescence, including the
development of autonomy from family, assimilation
with peers, separation from parents, and poorly devel-
oped abstract thinking and understanding of long-term
consequences of present actions, are often difficult to
balance with the behaviors required for optimal medi-
cation adherence.36
In practice, chronological age is the most common
criterion used to determine a patient’s readiness to
transfer from pediatric health care to adult-centered
health care, with 16 to 22 years being the most fre-
quently cited age range.37 Yet, consideration of self-
management skills is critical in determining a patient’s
progress toward independent health care management.
A shared management model of transition describes a
developmentally appropriate and systematic approach
to the gradual shifting of self-management responsibil-
ities from the healthcare provider and parent to the
adolescent.38 When the responsibility for health-related
tasks is shifted in a developmentally appropriate
manner, the adolescent gains the knowledge, skills,
and experiences necessary to master the indepen-
dence required to be successful in the adult health
care system.
DETERMINING READINESS TO TRANSFER
CARE
Researchers and clinicians agree that adolescents and
young adults should not transfer from pediatric health
services to adult health services unless they have the
skills necessary for functioning effectively in the adult
health care system.39,40 Recommendations for a suc-
cessful transition include (1) a written health care plan,
(2) the development of decision making and disease
self-management, (3) attention to educational and vo-
cational planning, (4) adequate insurance coverage, (5)
transfer of health care to a qualified and committed
adult specialist, and (6) involvement of the family in the
transition process,.39,41,42 Generally, the key elements
include the identification of a qualified and committed
adult team, the development of a specific written health
care transition plan, and the involvement of the family
in the transition process.42-44 Goals of transition pro-
grams include the promotion of skills in communica-
tion, decision making, assertiveness, self-care, and
self-advocacy.6
Specifically with respect to pediatric transplant recip-
ients, a recent consensus conference sponsored by sev-
eral transplant organizations to address issues related
to the transition from pediatric care to adult-centered
care identified critical milestones for adolescent and
young adult patients to achieve prior to transferring
care to the adult transplant clinic (Table 1).6 Overall, it
is recommended that prior to transferring to adult-cen-
tered care, pediatric transplant recipients should be
able to describe the reason for the transplant, be aware
of how transplantation affects their overall health, and
demonstrate a sense of responsibility and the capacity
to independently manage their health.6 Moreover, it has
been recommended that prior to physically transferring
to the adult-centered clinic, pediatric transplant recip-
ients should be able to describe their medication regi-
men, refill prescriptions independently, recognize how
TABLE 1. Tasks to Achieve Prior to Transfer of Care
1. Understanding of and the ability to describe the
original cause of the organ failure and the subsequent
need for transplantation
2. Awareness of the long-term and short-term
implications of the transplant condition on overall
health and other aspects of life
3. Knowledge related to medication, including the name,
dose, function, timing, and side effects
4. Comprehension of the impact of the illness/transplant
on reproductive health and sexuality
5. Demonstration of responsibility for one’s own health
care
6. Capacity to provide most self-care independently
7. Expressed readiness to move into adulthood
8. Ownership of medical information in a concise
portable medical summary
9. Adequate insurance coverage
NOTE: This table was adapted from Bell et al.6
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and when to seek medical attention, and be able to
communicate with their health care providers.6
In adult care settings, patients are expected to dem-
onstrate self-management skills, including the ability
to independently discuss medical care with the treat-
ment team, schedule and attend appointments, and
adhere to medications and treatment recommenda-
tions.45 The successful transition from pediatric health
care to adult-centered health care is contingent on the
acquisition of self-management skills while patients are
still being cared for by pediatric providers. As such,
interventions should target modifiable factors related to
the acquisition of the skills necessary for independent
health care management.
PREDICTORS OF SUCCESSFUL TRANSITION
Research is needed to define and identify predictors of a
successful transition in order to inform the develop-
ment of programs that target modifiable factors.46 Ini-
tial studies have focused on medical stability4,47 and
the initial attendance at a clinic appointment in the
adult health care center48 as markers of a successful
transition. It is important to underscore that transition
is a preparation process that occurs prior to and after
the shift in care. A primary outcome variable of the
transition process includes the transfer to adult-cen-
tered care (eg, a change of care provider and/or loca-
tion). However, there is no evidence to suggest that the
mere transfer of care is sufficient to promote long-term
positive health behaviors or outcomes. In addition to
clinic attendance, future research should assess the
impact of the health care transition on measures of
patient satisfaction, medical stability, quality of life,
psychosocial functioning, educational/vocational out-
comes, and health care utilization rates.
POTENTIAL RISKS AND BARRIERS
ASSOCIATED WITH MEDICATION
ADHERENCE AND TRANSITION
The limited data available (Scientific Registry of Trans-
plant Recipients/Organ Procurement and Transplanta-
tion Network data) suggest that the transfer to adult-
centered care does not increase graft loss; rather, the
increase in graft loss in adolescents begins in early
adolescence and continues into young adulthood.49
Medical regimen adherence has been suggested to be a
critical factor in the transition process because of an
association between nonadherence and an increased
risk of poor outcomes, including higher rates of graft
loss, following the transfer from pediatric care to adult-
centered care.4,5 There are 4 general categories of risk
factors associated with medication adherence, includ-
ing socioeconomic factors, patient-related factors, con-
dition-related and/or treatment-related factors, and
environmental variables.7 Within the transplant litera-
ture, medication nonadherence has been demonstrated
to be associated with inadequate regimen knowledge,
depression and anxiety, poor health-related quality of
life, low social support, substance abuse, life stress,
barriers to medication access, and a poor physician-
patient relationship.11,12,50-52 In addition, among ado-
lescent transplant recipients, medication nonadher-
ence has been associated with increased disease
frustration, poor regimen adaptation/cognitive issues,
difficulty with ingestion (eg, number of medications and
taste), and a lack of parental involvement.53 Targeting
barriers to medication adherence is a critical compo-
nent to transition planning.
In addition to medication nonadherence, there are
additional barriers to the transition of health care, in-
cluding patient-related factors, parent/caregiver fac-
tors, medical team factors, and systemic factors. Exam-
ples of barriers include the reluctance of patients,
parents, and pediatric physicians to transfer care (ie,
not “letting go”),43,54,55 a lack of trust between pediatric
and adult-care health providers,29,56 financial disin-
centives for transferring patients out of the pediatric
clinics,56 and adolescent psychosocial functioning and
medication nonadherence.39,57 Further research is
necessary to identify optimal strategies to prevent and
reconcile these barriers and risk factors.
INTERVENTIONS TO PROMOTE ADHERENCE
AND SELF-MANAGEMENT SKILLS
There are no empirically validated interventions to pro-
mote medication adherence or transition readiness in
pediatric transplant recipients. Given that adolescent
transplant recipients are at the highest risk for nonad-
herence14 and late graft loss associated with medica-
tion nonadherence,3 interventions aimed at improving
medication adherence in adolescent transplant recipi-
ents are critical. Self-management has been effective in
improving medication adherence in children with other
chronic health conditions.58,59 Key elements of self-
management include the promotion of health educa-
tion, communication skills, decision-making and prob-
lem-solving skills, and self-care in the context of
meaningful social support.60 Self-management skills
are integral to both optimal medication adherence and
the achievement of independence necessary for a suc-
cessful health care transition.61,62
TRANSITION PROGRAMS IN OTHER
PEDIATRIC POPULATIONS
Transition programs in other pediatric populations,
such as rheumatology,63 cystic fibrosis,64 and inflam-
matory bowel disease,65 can provide guidance for the
development of transition programs in pediatric solid
organ transplantation. For example, key components of
a transitional care program for adolescents with juve-
nile idiopathic arthritis include a resilience framework
to focus on the development of health-related informa-
tion and behavioral skills,63 including decision-mak-
ing, self-care, and self-management skills. The benefits
of transition programs in rheumatology include im-
proved quality of life, knowledge, health care satisfac-
tion, and vocational readiness.66 Existing transition
programs emphasize the use of transition timelines,
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which are constructed according to a developmental
framework that considers chronological age as well as
the developmental stage of the patient. These timelines
are individualized and emphasize the acquisition of
critical milestones, with respect to knowledge and self-
management skills, prior to the transfer of medical care
from a pediatric-focused clinic to an adult-focused
clinic. Sample transition timelines and checklists can
be found on the Children’s Digestive Health and Nutri-
tion Foundation Web site (http://www.cdhnf.org) and
on the Adolescent Health Transition Project Web site
(http://depts.washington.edu/healthtr).
Research suggests that transition preparation should
begin years prior to the anticipated change of medical
care providers.63-65 Yet, in order for transition prepa-
ration to lead to optimal long-term outcomes, it is nec-
essary to have an interested adult health care team to
provide care after transfer. Collaboration between pedi-
atric and adult transplant teams is essential, particu-
larly as evidence in other pediatric groups (eg, cystic
fibrosis) demonstrates that health outcomes are not
compromised when the transfer of care is a cooperative,
planned process between pediatric and adult care pro-
viders.67
ROLE OF CERTIFIED CLINICAL TRANSPLANT
COORDINATORS (CCTCS)
The Pediatric Committee of the American Society of
Transplantation has recommended that adolescent
transplant recipients have a designated health care
transition coordinator6 to facilitate the transition pro-
cess. Indeed, an identified transitional care coordinator
is a core component of transitional care as outlined in
national policy statements.42,68 Nurse practitioners are
most likely to serve as transition coordinators69; how-
ever, CCTCs are also in a position to take a leadership
role in transitional care programming. Specifically,
CCTCs can (1) educate patients and families about the
importance of transition readiness and the necessary
skills to promote a successful transfer of care, (2) facil-
itate communication regarding transition milestones
and readiness to transfer care, and (3) anticipate bar-
riers related to the transfer from pediatric care to adult-
centered care.
In collaboration with other medical team members,
CCTCs can assist adolescent transplant recipients in
working toward the achievement of critical tasks and
milestones (Tables 1 and 2). As key transition coordi-
nators, CCTCs can assist with the development of a
written health care transition plan that sets forth a
timeline for the achievement of self-management skills
to promote independence in health care management.
Transition coordinators can also assist with preparing
parents by educating them on strategies to increase the
adolescent’s responsibility for health care tasks in a
developmentally appropriate manner.
Not only can CCTCs assist families with the transi-
tion process, but they also can serve as liaisons at the
time of transfer by facilitating the transfer of health care
information in a portable, concise, up-to-date summary
of the adolescent’s medical/surgical history and medi-
cations.6 Although the successful transition from pedi-
atric health care to adult-centered health care is likely
contingent on the acquisition of self-management skills
while patients are still being cared for by pediatric pro-
viders, collaboration with interested adult transplant
care providers is critical to ensure optimal health care
transitions and long-term outcomes.70 Effective com-
munication between pediatric and adult services is im-
perative, and CCTCs on the adult transplant team can
assist with the transition process by collaborating with
pediatric transplant coordinators to facilitate the trans-
fer of care, including the transfer of relevant medical
information.
CONCLUSIONS
Nonadherence to posttransplant medical regimens is
associated with increased medical complications, graft
rejection, mortality, and health care utilization rates.
Adolescent solid organ transplant recipients are at a
higher risk for regimen nonadherence than younger
pediatric patients and adult recipients. Given that non-
adherence is associated with an increased risk for med-
ical complications, particularly among adolescent
transplant recipients, targeting problems of nonadher-
ence should be an essential component of the transition
process. Prospective research to validate a measure to
identify factors predictive of a successful transfer of
care and successful health outcomes is needed. Tran-
sition preparation is a continuous process and should
TABLE 2. Transition Planning Tasks: The Role of a
Clinical Transplant Coordinator
● Develop an individualized written health care transition
plan for each patient and his or her family.
● Develop a checklist of developmentally appropriate self-
management tasks and milestones to achieve prior to
transfer of care.
● Monitor progress using the checklist and the written
transition plan at each clinic visit, and set goals for
subsequent visits.
● Prepare and support parents in the transition process
by providing education on developmentally appropriate
tasks and goals for increasing the adolescent’s
responsibility for health care management.
● Encourage educational and vocational planning
throughout childhood and adolescence.
● Provide guidance and needed referrals to patients and
their families with respect to medical insurance
coverage prior to transfer of care.
● Collaborate with medical care providers to develop a
portable, up-to-date, concise medical summary for
each patient, and ensure that patients and their
families have copies of this summary.
● Facilitate communication between pediatric and adult
care providers prior to the transfer of care.
● Facilitate communication between each patient, his or
her family, and adult care providers with respect to the
logistics of the transfer of care (ie, clinic procedures,
location, and scheduling).
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incorporate interventions to promote self-management
skills and adherence as pediatric patients prepare to
move from child-centered care to adult-centered care.
CCTCs are well suited to serve as transition coordina-
tors to facilitate education, communication, and collab-
oration between patients, families, pediatric transplant
teams, and adult transplant teams.
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